|
1
|
Cabrera CV: Lateral inhibition and cell
fate during neurogenesis in Drosophila: The interactions between
scute, Notch and Delta. Development. 110:733–742. 1990.PubMed/NCBI
|
|
2
|
Schroeter EH, Kisslinger JA and Kopan R:
Notch-1 signalling requires ligand-induced proteolytic release of
intracellular domain. Nature. 393:382–386. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Logeat F, Bessia C, Brou C, LeBail O,
Jarriault S, Seidah NG and Israël A: The Notch1 receptor is cleaved
constitutively by a furin-like convertase. Proc Natl Acad Sci USA.
95:8108–8112. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blaumueller CM, Qi H, Zagouras P and
Artavanis-Tsakonas S: Intracellular cleavage of Notch leads to a
heterodimeric receptor on the plasma membrane. Cell. 90:281–291.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Groot AJ, Habets R, Yahyanejad S, Hodin
CM, Reiss K, Saftig P, Theys J and Vooijs M: Regulated proteolysis
of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins. Mol Cell
Biol. 34:2822–2832. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andersson ER, Sandberg R and Lendahl U:
Notch signaling: Simplicity in design, versatility in function.
Development. 138:3593–3612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Francis R, McGrath G, Zhang J, Ruddy DA,
Sym M, Apfeld J, Nicoll M, Maxwell M, Hai B, Ellis MC, et al: Aph-1
and pen-2 are required for Notch pathway signaling, gamma-secretase
cleavage of betaAPP, and presenilin protein accumulation. Dev Cell.
3:85–97. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Edbauer D, Winkler E, Regula JT, Pesold B,
Steiner H and Haass C: Reconstitution of gamma-secretase activity.
Nat Cell Biol. 5:486–488. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye
W, Wolfe MS and Selkoe DJ: Gamma-secretase is a membrane protein
complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc
Natl Acad Sci USA. 100:6382–6387. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takasugi N, Tomita T, Hayashi I, Tsuruoka
M, Niimura M, Takahashi Y, Thinakaran G and Iwatsubo T: The role of
presenilin cofactors in the gamma-secretase complex. Nature.
422:438–441. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hayashi I, Urano Y, Fukuda R, Isoo N,
Kodama T, Hamakubo T, Tomita T and Iwatsubo T: Selective
reconstitution and recovery of functional gamma-secretase complex
on budded baculovirus particles. J Biol Chem. 279:38040–38046.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mao L: NOTCH mutations: Multiple faces in
human malignancies. Cancer Prev Res (Phila). 8:259–261. 2015.
View Article : Google Scholar
|
|
13
|
Pannuti A, Foreman K, Rizzo P, Osipo C,
Golde T, Osborne B and Miele L: Targeting Notch to target cancer
stem cells. Clin Cancer Res. 16:3141–3152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao ZL, Zhang L, Huang CF, Ma SR, Bu LL,
Liu JF, Yu GT, Liu B, Gutkind JS, Kulkarni AB, et al: NOTCH1
inhibition enhances the efficacy of conventional chemotherapeutic
agents by targeting head neck cancer stem cell. Sci Rep.
6:247042016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yahyanejad S, Theys J and Vooijs M:
Targeting Notch to overcome radiation resistance. Oncotarget.
7:7610–7628. 2016. View Article : Google Scholar :
|
|
16
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Andersson ER and Lendahl U: Therapeutic
modulation of Notch signalling-are we there yet? Nat Rev Drug
Discov. 13:357–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Morohashi Y, Kan T, Tominari Y, Fuwa H,
Okamura Y, Watanabe N, Sato C, Natsugari H, Fukuyama T, Iwatsubo T
and Tomita T: C-terminal fragment of presenilin is the molecular
target of a dipeptidic gamma-secretase-specific inhibitor DAPT
(N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl
ester). J Biol Chem. 281:14670–14676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Haapasalo A and Kovacs DM: The many
substrates of presenilin/γ-secretase. J Alzheimers Dis. 25:3–28.
2011. View Article : Google Scholar
|
|
20
|
Mishra-Gorur K, Rand MD, Perez-Villamil B
and Artavanis-Tsakonas S: Down-regulation of Delta by proteolytic
processing. J Cell Biol. 159:313–324. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Araki Y, Tomita S, Yamaguchi H, Miyagi N,
Sumioka A, Kirino Y and Suzuki T: Novel cadherin-related membrane
proteins, Alcadeins, enhance the X11-like protein-mediated
stabilization of amyloid beta-protein precursor metabolism. J Biol
Chem. 278:49448–49458. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ando K, Iijima KI, Elliott JI, Kirino Y
and Suzuki T: Phosphorylation-dependent regulation of the
interaction of amyloid precursor protein with Fe65 affects the
production of beta-amyloid. J Biol Chem. 276:40353–40361. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okauchi T, Itonaga M, Minami T, Owa T,
Kitoh K and Yoshino H: A general method for acylation of indoles at
the 3-position with acyl chlorides in the presence of
dialkylaluminum chloride. Org Lett. 2:1485–1487. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Nakaya T, Kawai T and Suzuki T: Regulation
of FE65 nuclear translocation and function by amyloid beta-protein
precursor in osmotically stressed cells. J Biol Chem.
283:19119–19131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dovey HF, John V, Anderson JP, Chen LZ, de
Saint Andrieu P, Fang LY, Freedman SB, Folmer B, Goldbach E,
Holsztynska EJ, et al: Functional gamma-secretase inhibitors reduce
beta-amyloid peptide levels in brain. J Neurochem. 76:173–181.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Albano E, Rundgren M, Harvison PJ, Nelson
SD and Moldéus P: Mechanisms of N-acetyl-p-benzoquinone imine
cytotoxicity. Mol Pharmacol. 28:306–311. 1985.PubMed/NCBI
|
|
28
|
Kimberly WT, Zheng JB, Guénette SY and
Selkoe DJ: The intracellular domain of the beta-amyloid precursor
protein is stabilized by Fe65 and translocates to the nucleus in a
notch-like manner. J Biol Chem. 276:40288–40292. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao X and Südhof TC: Dissection of
amyloid-beta precursor protein-dependent transcriptional
transactivation. J Biol Chem. 279:24601–24611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
D'Angelo RC, Ouzounova M, Davis A, Choi D,
Tchuenkam SM, Kim G, Luther T, Quraishi AA, Senbabaoglu Y, Conley
SJ, et al: Notch reporter activity in breast cancer cell lines
identifies a subset of cells with stem cell activity. Mol Cancer
Ther. 14:779–787. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gupta-Rossi N, Le Bail O, Gonen H, Brou C,
Logeat F, Six E, Ciechanover A and Israël A: Functional interaction
between SEL-10, an F-box protein, and the nuclear form of activated
Notch1 receptor. J Biol Chem. 276:34371–34378. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oberg C, Li J, Pauley A, Wolf E, Gurney M
and Lendahl U: The Notch intracellular domain is ubiquitinated and
negatively regulated by the mammalian Sel-10 homolog. J Biol Chem.
276:35847–35853. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu G, Lyapina S, Das I, Li J, Gurney M,
Pauley A, Chui I, Deshaies RJ and Kitajewski J: SEL-10 is an
inhibitor of notch signaling that targets notch for
ubiquitin-mediated protein degradation. Mol Cell Biol.
21:7403–7415. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fryer CJ, White JB and Jones KA:
Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and
coordinate activation with turnover. Mol Cell. 16:509–520. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zage PE, Nolo R, Fang W, Stewart J,
Garcia-Manero G and Zweidler-McKay PA: Notch pathway activation
induces neuroblastoma tumor cell growth arrest. Pediatr Blood
Cancer. 58:682–689. 2012. View Article : Google Scholar :
|
|
36
|
Cheng YL, Choi Y, Seow WL, Manzanero S,
Sobey CG, Jo DG and Arumugam TV: Evidence that neuronal Notch-1
promotes JNK/c-Jun activation and cell death following ischemic
stress. Brain Res. 1586:193–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cama A, Verginelli F, Lotti LV, Napolitano
F, Morgano A, D'Orazio A, Vacca M, Perconti S, Pepe F, Romani F, et
al: Integrative genetic, epigenetic and pathological analysis of
para-ganglioma reveals complex dysregulation of NOTCH signaling.
Acta Neuropathol. 126:575–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ferrari-Toninelli G, Bonini SA, Uberti D,
Buizza L, Bettinsoli P, Poliani PL, Facchetti F and Memo M:
Targeting Notch pathway induces growth inhibition and
differentiation of neuroblastoma cells. Neuro Oncol. 12:1231–1243.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang M, Ma X, Wang J, Wang L and Wang Y:
Pretreatment with the γ-secretase inhibitor DAPT sensitizes
drug-resistant ovarian cancer cells to cisplatin by downregulation
of Notch signaling. Int J Oncol. 44:1401–1409. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shah MM, Zerlin M, Li BY, Herzog TJ,
Kitajewski JK and Wright JD: The role of Notch and gamma-secretase
inhibition in an ovarian cancer model. Anticancer Res. 33:801–808.
2013.PubMed/NCBI
|
|
41
|
Qiu H, Fang X, Luo Q and Ouyang G: Cancer
stem cells: A potential target for cancer therapy. Cell Mol Life
Sci. 72:3411–3424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Crabtree JS, Singleton CS and Miele L:
Notch signaling in neuroendocrine tumors. Front Oncol. 6:942016.
View Article : Google Scholar : PubMed/NCBI
|
